Minimal Residual Disease Testing Market Growth Trends 2025-2031: Growing Use of MRD Testing In Cases of Solid Tumors
Key Market Players Profiled include Illumina, Qiagen, PerkinElmer, F. Hoffmann-La Roche, Thermo Fisher Scientific, Natera, Bio-Rad Laboratories, Adaptive Biotechnologies, Sysmex, Integrated DNA Technologies, Twist Bioscience and Invivoscribe.Dublin, Dec. 27, 2024 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market Size, Share, Forecast, & Trends Analysis By Offering, Technology, Application Sample - Global Forecast to 2031" report has been added to ResearchAndMarkets.com's offering.